• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

1,1,1,3,3-Pentamethyl-3-phenyldisiloxane (CAS No. 14920-92-4): A Versatile Compound in Biomedical Research and Industrial Applications

1,1,1,3,3-Pentamethyl-3-phenyldisiloxane, with the chemical formula C₁₄H₃₀OSi, is a siloxane derivative that has garnered significant attention in the fields of pharmaceutical science, materials engineering, and biomedical technology. This compound is characterized by its unique molecular structure, which combines organic functional groups with silicon-based moieties, enabling it to exhibit exceptional physicochemical properties. The CAS No. 14920-92-4 identifier ensures its precise classification in chemical databases, facilitating global research collaboration and regulatory compliance. Recent studies have highlighted its potential applications in drug delivery systems, surface modification of medical devices, and as a precursor for advanced biomaterials.

Recent advancements in nanotechnology have expanded the utility of 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane in biomedical contexts. For instance, researchers at the University of Tokyo (2023) demonstrated its role as a stabilizing agent in the synthesis of polymeric nanoparticles for targeted drug delivery. The compound’s ability to form stable colloidal suspensions in aqueous environments makes it particularly suitable for encapsulating hydrophobic therapeutics, such as antifungal agents and anti-cancer drugs. This application aligns with the growing demand for biocompatible materials that can enhance drug bioavailability while minimizing systemic toxicity.

Another critical area of research involves the use of 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane in surface engineering for medical implants. A 2024 study published in Advanced Healthcare Materials revealed that coatings derived from this compound significantly reduced bacterial adhesion on titanium alloys used in orthopedic implants. The compound’s hydrophobic surface properties, combined with its low surface energy, create a barrier against microbial colonization, thereby reducing the risk of implant-related infections. This finding underscores its potential in addressing global challenges in antimicrobial resistance.

Furthermore, the compound’s role in the development of smart biomaterials has been a focal point in recent years. A collaborative effort between the National Institute of Standards and Technology (NIST) and the University of California, Berkeley (2023) explored its integration into stimuli-responsive hydrogels. These hydrogels, triggered by pH or temperature changes, can release therapeutic agents in a controlled manner, offering precise treatment options for chronic diseases such as diabetes and arthritis. The CAS No. 14920-92-4 compound’s ability to modulate the mechanical properties of hydrogels while maintaining biocompatibility makes it a cornerstone in this emerging field.

Environmental considerations have also driven innovation in the application of 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane. Researchers at the European Polymer Institute (2024) investigated its use in biodegradable polymer composites for sustainable packaging and medical waste management. The compound’s compatibility with natural polymers like cellulose and chitosan enables the creation of materials that degrade under physiological conditions, reducing environmental impact. This aligns with the broader industry shift toward green chemistry and eco-friendly manufacturing processes.

In the realm of diagnostic imaging, 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane has shown promise as a contrast agent for magnetic resonance imaging (MRI). A 2023 study in Contrast Media & Molecular Imaging reported that its silicon-oxygen backbone enhances T2 relaxation times, improving image resolution for soft tissue visualization. This property is particularly valuable in early-stage cancer detection, where high-resolution imaging is critical for accurate diagnosis and treatment planning.

Industrial applications of this compound extend beyond biomedical uses. In the cosmetics industry, 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane is employed as a silicone-based emollient due to its ability to form a protective layer on the skin. Its non-irritating nature and compatibility with other skincare ingredients make it a preferred choice for formulations targeting sensitive skin conditions. This dual functionality in both pharmaceutical and cosmetic sectors highlights its versatility as a multifunctional compound.

The synthesis of 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane involves a series of controlled chemical reactions, including the coupling of organosilanes with phenyl groups. A 2022 review in Organic & Biomolecular Chemistry detailed the optimization of reaction conditions, such as temperature, catalyst selection, and solvent polarity, to achieve high yields and purity. These synthetic strategies are critical for large-scale production, ensuring the compound meets the stringent quality standards required for pharmaceutical and industrial applications.

Regulatory frameworks governing the use of 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane are continuously evolving to address safety and environmental concerns. The U.S. Environmental Protection Agency (EPA) and the European Chemicals Agency (ECHA) have established guidelines for its use in consumer products, emphasizing the need for rigorous toxicological testing. Ongoing research aims to further elucidate its long-term effects, ensuring its safe integration into medical and industrial applications.

As the demand for advanced biomaterials and targeted therapies grows, 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane is poised to play a pivotal role in shaping the future of healthcare. Its unique chemical properties, coupled with ongoing innovations in nanotechnology and green chemistry, position it as a key player in the development of next-generation medical devices, drug delivery systems, and sustainable materials. The compound’s journey from a specialized chemical to a cornerstone of modern biotechnology exemplifies the dynamic interplay between scientific discovery and practical application.

Looking ahead, the integration of 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane into emerging technologies such as 3D bioprinting and wearable medical devices is expected to unlock new possibilities. For example, its use in bioprinted tissues could enable the creation of complex, functional organoids for drug testing and regenerative medicine. Additionally, its incorporation into flexible electronics for health monitoring devices may revolutionize personalized healthcare by providing real-time data on physiological parameters.

In conclusion, 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane represents a remarkable example of how a single chemical compound can transcend traditional boundaries to impact diverse fields. Its contributions to biomedical innovation, environmental sustainability, and industrial applications underscore its significance in the modern scientific landscape. As research continues to uncover new properties and applications, the compound’s role in advancing human health and technological progress is likely to expand further, solidifying its place as a cornerstone of interdisciplinary innovation.

For further information on the latest developments in 1,1,1,3,3-Pentamethyl-3-phenyldisiloxane research, readers are encouraged to explore the referenced studies and industry reports cited in this discussion. Engaging with ongoing scientific discourse will provide valuable insights into the compound’s evolving role in addressing global challenges across multiple domains.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)